Eli Lilly granted Prasco rights to market authorized generic versions of neurology drugs Zyprexa olanzapine and Zyprexa Zydis oral disintegrating tablets in the U.S.

Eli Lilly and Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Prasco Laboratories

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced